Safety and Efficacy of 6-thioguanine as a Second-line Treatment for Autoimmune Hepatitis

Clin Gastroenterol Hepatol. 2018 Feb;16(2):290-291. doi: 10.1016/j.cgh.2017.07.032. Epub 2017 Aug 3.
No abstract available

MeSH terms

  • Aged
  • Anti-Inflammatory Agents / administration & dosage*
  • Anti-Inflammatory Agents / adverse effects*
  • Drug-Related Side Effects and Adverse Reactions / epidemiology*
  • Drug-Related Side Effects and Adverse Reactions / pathology
  • Female
  • Hepatitis, Autoimmune / drug therapy*
  • Humans
  • Male
  • Middle Aged
  • Thioguanine / administration & dosage*
  • Thioguanine / adverse effects*
  • Treatment Outcome

Substances

  • Anti-Inflammatory Agents
  • Thioguanine